Jackson Grant Investment Advisers Inc. Raises Holdings in UnitedHealth Group Incorporated (UNH)

Jackson Grant Investment Advisers Inc. raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.4% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,101 shares of the healthcare conglomerate’s stock after buying an additional 4 shares during the period. Jackson Grant Investment Advisers Inc.’s holdings in UnitedHealth Group were worth $204,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the business. Harbour Capital Advisors LLC lifted its stake in shares of UnitedHealth Group by 18,383.4% in the 2nd quarter. Harbour Capital Advisors LLC now owns 2,516,706 shares of the healthcare conglomerate’s stock valued at $13,573,000 after purchasing an additional 2,503,090 shares during the last quarter. Jennison Associates LLC lifted its stake in shares of UnitedHealth Group by 180.4% in the 2nd quarter. Jennison Associates LLC now owns 2,252,507 shares of the healthcare conglomerate’s stock valued at $417,660,000 after purchasing an additional 1,449,130 shares during the last quarter. State Street Corp lifted its stake in shares of UnitedHealth Group by 2.5% in the 1st quarter. State Street Corp now owns 45,724,509 shares of the healthcare conglomerate’s stock valued at $7,499,276,000 after purchasing an additional 1,122,534 shares during the last quarter. Ameriprise Financial Inc. lifted its stake in shares of UnitedHealth Group by 29.9% in the 1st quarter. Ameriprise Financial Inc. now owns 3,332,761 shares of the healthcare conglomerate’s stock valued at $546,574,000 after purchasing an additional 766,573 shares during the last quarter. Finally, American Century Companies Inc. lifted its stake in shares of UnitedHealth Group by 16.9% in the 2nd quarter. American Century Companies Inc. now owns 4,703,113 shares of the healthcare conglomerate’s stock valued at $872,051,000 after purchasing an additional 681,111 shares during the last quarter. 86.00% of the stock is owned by institutional investors.

Several research firms recently issued reports on UNH. Royal Bank Of Canada reaffirmed a “buy” rating and issued a $212.00 price objective on shares of UnitedHealth Group in a research note on Thursday, July 20th. Citigroup Inc. lifted their target price on shares of UnitedHealth Group from $195.00 to $213.00 and gave the stock a “buy” rating in a report on Wednesday, July 19th. Sanford C. Bernstein reiterated an “outperform” rating and issued a $210.00 target price (up previously from $190.00) on shares of UnitedHealth Group in a report on Saturday, July 22nd. Cowen and Company reiterated an “outperform” rating and issued a $220.00 target price (up previously from $175.00) on shares of UnitedHealth Group in a report on Friday, August 11th. Finally, Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $215.00 target price on the stock in a report on Tuesday, August 1st. Three analysts have rated the stock with a hold rating and twenty-four have issued a buy rating to the stock. UnitedHealth Group has an average rating of “Buy” and an average price target of $216.65.

UnitedHealth Group Incorporated (NYSE:UNH) opened at $212.66 on Tuesday. The company has a market cap of $204,541.08, a PE ratio of 21.99, a price-to-earnings-growth ratio of 1.57 and a beta of 0.64. UnitedHealth Group Incorporated has a 12-month low of $147.04 and a 12-month high of $213.93. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.70 and a quick ratio of 0.70.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, beating the Zacks’ consensus estimate of $2.57 by $0.09. The firm had revenue of $50.32 billion for the quarter, compared to analyst estimates of $50.38 billion. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The company’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period in the previous year, the business earned $2.17 earnings per share. equities research analysts predict that UnitedHealth Group Incorporated will post 9.99 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Friday, December 1st will be given a $0.75 dividend. The ex-dividend date is Thursday, November 30th. This represents a $3.00 dividend on an annualized basis and a yield of 1.41%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 33.26%.

ILLEGAL ACTIVITY NOTICE: “Jackson Grant Investment Advisers Inc. Raises Holdings in UnitedHealth Group Incorporated (UNH)” was originally published by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of international copyright & trademark laws. The original version of this piece of content can be accessed at https://www.chaffeybreeze.com/2017/11/14/jackson-grant-investment-advisers-inc-raises-holdings-in-unitedhealth-group-incorporated-unh.html.

In other news, Director Gail R. Wilensky sold 5,600 shares of the company’s stock in a transaction that occurred on Tuesday, September 5th. The shares were sold at an average price of $199.49, for a total transaction of $1,117,144.00. Following the transaction, the director now directly owns 60,834 shares in the company, valued at $12,135,774.66. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Thomas E. Roos sold 975 shares of the company’s stock in a transaction that occurred on Thursday, October 19th. The stock was sold at an average price of $205.47, for a total transaction of $200,333.25. Following the transaction, the insider now owns 24,630 shares in the company, valued at $5,060,726.10. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 72,149 shares of company stock worth $14,212,342. Company insiders own 0.89% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply